OBERWEIS ASSET MANAGEMENT INC/ GMED Globus Medical, Inc.-A

Ownership history in OBERWEIS ASSET MANAGEMENT INC/  ·  4 quarters on record

AI Ownership Summary

OBERWEIS ASSET MANAGEMENT INC/ reported Globus Medical, Inc.-A (GMED) in 4 quarterly 13F filings from 2025 Q4 through 2026 Q1. Peak portfolio weight reached 1.0% in 2026 Q1. The latest visible filing shows GMED at 1.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this GMED ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was OBERWEIS ASSET MANAGEMENT INC/'s position in Globus Medical, Inc.-A, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

GMED was reported at 1.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
1.0% in 2026 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2025 Q4 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How OBERWEIS ASSET MANAGEMENT INC/ held GMED — position size vs. price
% of Fund (quarterly)    GMED price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 2 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 ADDED 392,200 +122,200 +45.3% 1.00% $33.8M 2026-05-15 $76.64
2025 Q4 ADDED 270,000 +254,800 +1676.3% 0.86% $23.6M 2026-02-17 $89.00
2 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

FAQ About OBERWEIS ASSET MANAGEMENT INC/ and GMED

These are the practical questions this page is built to answer before you even open the full history table.

How long has OBERWEIS ASSET MANAGEMENT INC/ reported owning GMED?

OBERWEIS ASSET MANAGEMENT INC/ reported GMED across 2 quarterly 13F filings, from 2025 Q4 through 2026 Q1.

What was the largest reported GMED position in OBERWEIS ASSET MANAGEMENT INC/'s portfolio?

The largest reported portfolio weight for GMED was 1.00% in 2026 Q1.

What is the latest reported GMED position on this page?

The most recent filing on this page is 2026 Q1, when OBERWEIS ASSET MANAGEMENT INC/ reported 392,200 shares, equal to 1.00% of portfolio, with an estimated market value of $33.8M.

What does the chart on this GMED ownership page compare?

The chart compares OBERWEIS ASSET MANAGEMENT INC/'s quarterly GMED portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did OBERWEIS ASSET MANAGEMENT INC/ time their GMED position?

Based on 13F filing dates vs. subsequent GMED price moves, OBERWEIS ASSET MANAGEMENT INC/ correctly timed 2 out of 3 reported position changes (67%).

← Back to OBERWEIS ASSET MANAGEMENT INC/ Holdings